Top Health Tech Companies in Seattle, WA (253)
Headway’s mission is a big one – to build a new mental health care system everyone can access. We’ve built technology that helps people find great therapists with the first software-enabled national network of providers accepting insurance. 1 in 4 people in the US have a treatable mental health condition, but the majority of providers don’t accept insurance, making therapy...
Headway's Top Stability & Growth Strengths
Market Expansion: Operations span all 50 states and Washington, D.C., with coverage reported across 100+ health plans and expansion into Medicare Advantage and Medicaid. This broadened payer and geographic footprint increases addressable demand and distribution leverage.
Product Line Growth: Offerings have expanded beyond matching into EHR, AI‑assisted notes, telehealth, billing, integrated‑care referrals, and a patient app. These additions deepen provider engagement and create more touchpoints for utilization and scale.
Strong Revenue Growth: Annual revenue is described as having more than doubled over a recent 12‑month period in 2024, indicating accelerating commercial momentum. While later‑period figures are not disclosed, the earlier surge aligns with rapid operating scale increases.
Who We Are Chewy is where pet parents find everything they need for life with pets, from food to fun to pharmacy. We make pet care easier, more informed, and more joyful through fast, reliable delivery and award-winning 24/7 Customer Care, including access to pet health support when it’s needed. Founded in 2011, Chewy combines the convenience of online shopping with...
Chewy's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Revenue has risen at a steady mid- to high-single-digit pace—FY2025 grew 8.3% on a normalized basis, with FY2026 Q1 and Q2 up 7.7% and 7.3% respectively, alongside 3.8% active-customer growth. Management also raised its FY2026 net sales outlook, pointing to continued expansion.
Customer Loyalty & Retention: Autoship sales increased 9.3% in Q2 FY2026 to about $2.82 billion and represented 84.6% of total sales, supporting predictable, repeat purchasing. Sales per active customer also edged up to $602, indicating deepening engagement.
Profitability: Adjusted EBITDA climbed 23.7% in Q2 FY2026 to $226.7 million with a 6.8% margin, and net income rose year over year. These gains indicate improving operating earnings alongside growth.
Artera is a patient communication and engagement platform designed to assist healthcare providers in managing and automating interactions with patients through various channels, including text, email, phone, and voice AI agents. This innovative solution caters to a diverse range of healthcare entities, such as specialty practices, Federally Qualified Health Centers (FQHCs), health systems, and federal agencies, all of which require...
Artera's Top Stability & Growth Strengths
Strong Revenue Growth: Reported $100M in contracted annual recurring revenue and placements on Deloitte Technology Fast 500 and Inc. 5000 indicate substantial multi‑year expansion. These signals point to meaningful top‑line momentum at scale.
Investor Backing & Capital Strength: A $65M growth investment from existing investors provides capital to accelerate expansion and AI adoption. This backing suggests solid financial support and runway.
Innovation-Driven Growth: Adoption of AI agents and co‑pilots across hundreds of providers, plus expansion into new workflows, shows product‑led growth beyond core messaging. FedRAMP authorization further enables innovation to reach federal healthcare settings.
We bring together clinical expertise, always-on tools, and deep insights so clients can improve their lives, providers can build practices they're proud of, and businesses can offer more effective, more efficient care. We believe mental health is a never-ending pursuit, and we build toward that progress every day. For our team, that means a day's work can literally change someone's life....
Grow Therapy's Top Stability & Growth Strengths
Strong Revenue Growth: Feedback suggests revenue expanded rapidly, highlighted by a first-place ranking in the FT’s 2026 Americas’ Fastest-Growing Companies based on 2021–2024 growth and a reported $617.4M in 2024 revenue. Additional signals include reported surges in appointments and broader commercial activity across 2025–2026.
Investor Backing & Capital Strength: Feedback suggests substantial access to capital, including a $150M Series D in March 2026 and cumulative funding of about $328M. This capital appears to support expansion into insurers, employers, and health-system partnerships.
Market Expansion: Feedback suggests the company expanded distribution via 125+ health-plan partners (later 135), employer benefits, and health-system integrations. These channels appear to broaden reach beyond direct patient acquisition.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for...
Pfizer's Top Stability & Growth Strengths
Product Line Growth: Newer and acquired medicines grew 18% operationally in Q2 2026, while revenue excluding Comirnaty and Paxlovid rose 5% operationally in the same period. Excluding COVID products, 2025 revenue also increased 6% operationally, supported by growth in products such as Eliquis and Padcev.
Cost & Operational Efficiency: Management is pursuing additional savings to improve operational efficiency and support profitability. These cost-control efforts are intended to help the business transition away from pandemic-driven sales while supporting margins.
Innovation-Driven Growth: Investment in future growth includes $10.4 billion in internal R&D during 2025 and ongoing development in oncology and obesity. A broad pipeline and recent acquisitions are intended to offset declining COVID-19 sales and patent expirations if programs succeed.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Headcount and hiring momentum are evident, with third-party estimates showing growth from roughly the mid‑teens of thousands in 2024 to 20,000+ by 2025–2026 and plans to hire thousands, alongside new capacity such as the Hyderabad operations center. This suggests the company is scaling delivery and talent depth across geographies.
Innovation-Driven Growth: The firm has expanded into AI and digital offerings, including its ZAIDYN platform, acquisitions like Digital Additive and Torrent Consulting, and launches such as Myelo developed with the International Myeloma Foundation. These moves indicate investment beyond traditional consulting into scalable, tech‑enabled services.
Market Expansion: A dedicated mid‑cap pharmaceutical vertical and the opening of an operations center in Hyderabad point to deliberate expansion in target segments and delivery footprint. These steps signal efforts to broaden served markets and strengthen execution capacity.
We are a tight-knit team of versatile R&D creatives based in Seattle. We work with companies of all sizes to conceptualize, design, and develop new products, often with emerging technology. Our approach blends artistic creativity with engineering precision and is based on our deep history with hard goods, soft goods, and technology. This unique foundation allows us to excel at projects...
_23.png)
Anatomy Next is human body simulator for medical training in virtual reality.
_9.png)
Array Health personalizes the health insurance experience similar to retail e-commerce, giving consumers real-time access and choice, so that they may proactively manage their coverage and related costs.
Freespira, Inc. is the maker of Freespira, the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder, and post-traumatic stress disorder (PTSD) in just 28 days by training users to normalize respiratory irregularities. Health plans, self-insured employers and the Veteran’s Administration use the company’s drug-free solutions to improve quality of life, reduce medical...
We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—whether you’re a provider, drug developer, hospital, medical researcher or patient. That means everything from advancing diagnostic testing to helping launch new drugs, to offering new perspectives through data - all drawing from a deep...
MeBe is a provider of evidence-based therapies for children with autism and other special needs. Their mission is to empower families, professionals, and communities by educating and training them on evidence-based approaches, offering play-filled, research-based care across multiple disciplines.
EvergreenHealth is a community-owned, independent public hospital system serving communities in Washington’s north King and south Snohomish counties. With hospitals in Kirkland and Monroe, plus dozens of regional practices, it provides more than 80 primary and specialty services through over 1,100 physicians. Its mission centers on delivering accessible, high-quality, personalized care while supporting community health, education, outreach, wellness, patients, and...
EviDent Alliance is a doctor-owned, doctor-led dental support organization serving practices across the Pacific Northwest. It handles operational work—including human resources, recruiting, payroll, marketing, IT, purchasing, accounting, and finance—so dentists can focus on patient care while retaining clinical autonomy and practice culture. Its collaborative model supports care centers and aims to foster high-quality dentistry, sustainable practice growth, better patient outcomes,...
_24.png)
Translational Software is enabling healthcare providers to realize the promise of precision medicine. We simplify complex genetic data into evidence-based actionable recommendations and deliver information in platform agnostic formats. Our vision is to inform clinical decisions affecting patients around the world with the best available personalize
Who is Edifecs? Edifecs is a leading healthcare technology company with the mission to improve healthcare outcomes, reduce costs and accelerate innovation. In a world that includes hundreds of millions of consumers and millions of care delivery sites and people, we deliver a single point solution to connect to all information exchange partners and to ingest, correlate and optimize digital health...
Perimatics is a partnership of Winigent, University of Washington CoMotion Team, and Microsoft for Startups. We brought together Physicians, Data Scientists, Data Engineers, and Clinical Researchers to develop Predictive and Real Time Decision Support Platforms. Our Perioperative applications are personalized for Physicians and Clinicians to deliver better outcomes at the point of care.
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence...
Shift Labs makes medical devices that place technology and design on equal footing to create affordable solutions. We emphasize simplicity and create devices that serve the fastest growing healthcare markets in the world.
.png){kind=logo}
ResCare Community Living has four decades of experience in the disability services field, providing support to individuals who need assistance with daily living due to an intellectual, developmental or cognitive disability. Our community living services are provided in 27 states with several thousand programs and a comprehensive range of high-quality services, including: Community Living, Adult Host Homes for adults regardless...
ResCare Community Living's Top Stability & Growth Strengths
Strong Market Position & Advantage: RCL operated at national scale and, following its March 31, 2026 sale, now sits within Sevita, which regulators and industry coverage repeatedly describe as the largest U.S. provider in IDD community-based services; required FTC divestitures further underline the combined platform’s market heft.
Market Expansion: The acquisition is framed as expanding Sevita’s home- and community-based services nationwide, absorbing a roughly $1.2B-revenue multi‑state program base to reach more people across many states.
Strong Brand Reputation: Decades-long legacy under the ResCare name and cited CARF and BHCOE accreditations signal recognized standards and credibility across multiple states.
